Old Web
English
Sign In
Acemap
>
Paper
>
833O A phase Ib study result of HMPL-689, a PI3Kδ inhibitor, in Chinese patients with relapsed/refractory lymphoma
833O A phase Ib study result of HMPL-689, a PI3Kδ inhibitor, in Chinese patients with relapsed/refractory lymphoma
2021
Junning Cao
Zhiming Li
Jian Zhou
Qian Zhang
Yu Chen
Z. Zhu
Lei Li
R. Feng
F. Li
B. Xu
W. Yang
Z. Zhai
Xiao-Hui Zhang
Q. Wen
H. Xue
X Duan
S. Fan
Y. Cai
W. Su
Keywords:
Oncology
Lymphoma
relapsed refractory
Internal medicine
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]